ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

VRAX // Virax Biolabs Group Limited

DIV <GO> NASDAQ RQD COCKPIT → CIK 0001885827 ↗
Health Care • Biotechnology: In Vitro & In Vivo Diagnostic Substances
$1.32 ▲ +0.12 (+10.00%)
MKT CAP: $1.8M • VOL: 58.3K
CASH DIVIDEND YIELD
0.00%
ANNUAL RATE: $0.00 / SH
TOTAL SHAREHOLDER YIELD
1.85%
BUYBACK YIELD: 1.85%
FCF PAYOUT COVERAGE RATIO
0.0%
GAAP EPS PAYOUT: 0.0%
DIVIDEND SAFETY SCORE NO DIVIDEND
50/100
GROWTH STREAK: 0 CONSECUTIVE YRS
VRAX // EX-DIVIDEND & CAPITAL DISTRIBUTION SCHEDULE (DIV <GO>) SPOT: $1.32
Virax Biolabs Group Limited (VRAX) DOES NOT CURRENTLY DISTRIBUTE A REGULAR CASH DIVIDEND. CAPITAL ALLOCATION PRIORITIZES INTERNAL R&D (— ROIC) AND OPPORTUNISTIC SHARE REPURCHASES (1.85% BUYBACK YIELD).